Free Trial

Haleon PLC Sponsored ADR $HLN Stake Lessened by Procyon Advisors LLC

Haleon logo with Medical background

Key Points

  • Procyon Advisors LLC significantly reduced its stake in Haleon PLC by 93.2%, owning only 17,932 shares after selling 244,898 shares during the second quarter.
  • Several institutional investors, including Nuveen LLC and Millennium Management LLC, have increased their holdings in Haleon, indicating growing interest from large investors in the company's stock.
  • Haleon recently announced a semi-annual dividend of $0.0555 per share, marking an increase from the previous dividend, representing a dividend yield of 190.0%.
  • MarketBeat previews top five stocks to own in October.

Procyon Advisors LLC lessened its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 93.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,932 shares of the company's stock after selling 244,898 shares during the quarter. Procyon Advisors LLC's holdings in Haleon were worth $186,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HLN. Allspring Global Investments Holdings LLC lifted its holdings in Haleon by 6.1% during the first quarter. Allspring Global Investments Holdings LLC now owns 30,223 shares of the company's stock valued at $306,000 after purchasing an additional 1,749 shares during the last quarter. Acadian Asset Management LLC purchased a new stake in shares of Haleon during the first quarter valued at approximately $1,767,000. Oppenheimer & Co. Inc. lifted its stake in Haleon by 11.2% in the first quarter. Oppenheimer & Co. Inc. now owns 25,362 shares of the company's stock worth $261,000 after acquiring an additional 2,564 shares during the period. Concurrent Investment Advisors LLC lifted its stake in Haleon by 32.9% in the first quarter. Concurrent Investment Advisors LLC now owns 16,363 shares of the company's stock worth $168,000 after acquiring an additional 4,055 shares during the period. Finally, Mather Group LLC. raised its holdings in Haleon by 60.7% in the first quarter. Mather Group LLC. now owns 9,036 shares of the company's stock worth $93,000 after purchasing an additional 3,413 shares in the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on HLN shares. Barclays downgraded Haleon from an "overweight" rating to an "equal weight" rating in a report on Tuesday, September 16th. The Goldman Sachs Group upgraded Haleon from a "neutral" rating to a "buy" rating in a research note on Wednesday, September 10th. BNP Paribas Exane raised Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price objective on the stock in a research report on Tuesday, May 27th. BNP Paribas upgraded Haleon to a "strong-buy" rating in a research note on Tuesday, May 27th. Finally, Wall Street Zen downgraded Haleon from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Two investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have given a Hold rating to the company's stock. Based on data from MarketBeat, Haleon has an average rating of "Moderate Buy" and an average target price of $12.33.

View Our Latest Stock Report on Haleon

Haleon Trading Up 0.0%

HLN stock traded up $0.00 during trading on Tuesday, reaching $9.00. 1,906,498 shares of the stock traded hands, compared to its average volume of 12,391,335. The business's 50 day moving average price is $9.64 and its 200-day moving average price is $10.15. Haleon PLC Sponsored ADR has a 52-week low of $8.86 and a 52-week high of $11.42. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63. The firm has a market capitalization of $40.28 billion, a PE ratio of 23.06, a P/E/G ratio of 2.71 and a beta of 0.23.

Haleon Increases Dividend

The company also recently disclosed a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were paid a dividend of $0.0555 per share. The ex-dividend date was Friday, August 15th. This is an increase from Haleon's previous semi-annual dividend of $0.05. This represents a yield of 190.0%. Haleon's payout ratio is currently 28.21%.

Haleon Profile

(Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Featured Stories

Institutional Ownership by Quarter for Haleon (NYSE:HLN)

Should You Invest $1,000 in Haleon Right Now?

Before you consider Haleon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.

While Haleon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.